Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-01
DOI
10.3389/fcell.2021.773048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- [18F]-C-SNAT4: an improved caspase-3-sensitive nanoaggregation PET tracer for imaging of tumor responses to chemo- and immunotherapies
- (2021) Min Chen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway
- (2020) Xiao‐Zhong Liao et al. PHYTOTHERAPY RESEARCH
- Commercialization of Organoids
- (2020) Deepak Choudhury et al. TRENDS IN MOLECULAR MEDICINE
- miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway
- (2020) Wu Yang et al. OncoTargets and Therapy
- Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput
- (2020) Erin Maloney et al. Micromachines
- Dandelion Polysaccharide Exerts Anti-Angiogenesis Effect on Hepatocellular Carcinoma by Regulating VEGF/HIF-1α Expression
- (2020) Feng Ren et al. Frontiers in Pharmacology
- Silencing c-Myc Enhances the Antitumor Activity of Bufalin by Suppressing the HIF-1α/SDF-1/CXCR4 Pathway in Pancreatic Cancer Cells
- (2020) Xia Liu et al. Frontiers in Pharmacology
- EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis
- (2020) Chi-Chen Fan et al. Redox Biology
- Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway
- (2020) Yaqiu Wang et al. LIFE SCIENCES
- Establishment of patient-derived cancer organoids for drug-screening applications
- (2020) Else Driehuis et al. Nature Protocols
- PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
- (2020) Rui Liu et al. Cell Death & Disease
- The Next Wave of Stroma-Targeting Therapy in Pancreatic Cancer
- (2019) Huocong Huang et al. CANCER RESEARCH
- Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase
- (2019) Belén G. Sánchez et al. Cancer Cell International
- AKT and ERK dual inhibitors: The way forward?
- (2019) Zhe Cao et al. CANCER LETTERS
- Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
- (2019) Shangze Li et al. CANCER RESEARCH
- Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
- (2019) I. Ubink et al. BRITISH JOURNAL OF SURGERY
- Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation
- (2019) Cheri A. Pasch et al. CLINICAL CANCER RESEARCH
- Recent Study of Dual HDAC/PARP Inhibitor for the Treatment of Tumor
- (2019) Haiying Lu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A Novel HIF Inhibitor Halofuginone Prevents Neurodegeneration in a Murine Model of Retinal Ischemia-Reperfusion
- (2019) Hiromitsu Kunimi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening
- (2019) Matteo Boretto et al. NATURE CELL BIOLOGY
- Resistance to TRK inhibition mediated by convergent MAPK pathway activation
- (2019) Emiliano Cocco et al. NATURE MEDICINE
- Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
- (2019) Ye Yao et al. Cell Stem Cell
- Organoid cultures as preclinical models of non-small cell lung cancer
- (2019) Ruoshi Shi et al. CLINICAL CANCER RESEARCH
- Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
- (2019) Salo N. Ooft et al. Science Translational Medicine
- The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy
- (2019) Fan Liang et al. Oncogenesis
- MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma
- (2018) Andrea Lampis et al. GASTROENTEROLOGY
- Halofuginone-induced autophagy suppresses the migration and invasion of MCF-7 cells via regulation of STMN1 and p53
- (2018) Xiaojing Xia et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Patient derived organoids to model rare prostate cancer phenotypes
- (2018) Loredana Puca et al. Nature Communications
- Multi-target natural products as alternatives against oxidative stress in Chronic Obstructive Pulmonary Disease (COPD)
- (2018) Priscila Baltazar Gonçalves et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
- (2017) Kouhei Tsuchida et al. FREE RADICAL BIOLOGY AND MEDICINE
- FGFR2 regulation by picrasidine Q inhibits the cell growth and induces apoptosis in esophageal squamous cell carcinoma
- (2017) Yuanyuan Shi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Halofuginone dually regulates autophagic flux through nutrient-sensing pathways in colorectal cancer
- (2017) Guo-Qing Chen et al. Cell Death & Disease
- cis -Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer Independent
- (2017) Yue Huang et al. Cell Reports
- Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells
- (2017) Yani Fang et al. PLoS One
- One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
- (2016) Han-Sen Chen et al. Current Neuropharmacology
- A multi-residue method for 17 anticoccidial drugs and ractopamine in animal tissues by liquid chromatography-tandem mass spectrometry and time-of-flight mass spectrometry
- (2016) Johanna L. Matus et al. Drug Testing and Analysis
- Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft model
- (2016) Faezeh Koohestani et al. HUMAN REPRODUCTION
- Evaluation and Elucidation Studies of Natural Aglycones for Anticancer Potential using Apoptosis-Related Markers: An In silico Study
- (2016) Salman Akhtar et al. Interdisciplinary Sciences-Computational Life Sciences
- Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase
- (2016) Stephen Nakazawa Hewitt et al. ACS Infectious Diseases
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer’s Disease Phenotypes
- (2016) Waseem K. Raja et al. PLoS One
- Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone
- (2015) Zhuang Cui et al. ANNALS OF THE RHEUMATIC DISEASES
- Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases
- (2015) Fleur Weeber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model
- (2015) Bhagwan Yadav et al. Computational and Structural Biotechnology Journal
- Multi-target approach for natural products in inflammation
- (2014) Andreas Koeberle et al. DRUG DISCOVERY TODAY
- Organogenesis in a dish: Modeling development and disease using organoid technologies
- (2014) M. A. Lancaster et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now